CYTEK(CTKB)2025-02-27 21:09Financial Results Announcement - Cytek Biosciences, Inc. announced preliminary unaudited revenue for Q4 2024 and full year ended December 31, 2024[4]. - The press release regarding the financial results was issued on January 15, 2025[4]. - The report does not include detailed financial figures or performance metrics in the provided content[4]. - The financial results are not deemed "filed" under the Securities Exchange Act of 1934[5]. Company Information - The company is listed on the Nasdaq Global Select Market under the symbol CTKB[2]. - The company is not classified as an emerging growth company[3]. - The filing does not include any new or revised financial accounting standards compliance[3]. - The report includes an interactive data file as part of the exhibits[7]. - The report was signed by Wenbin Jiang, President and CEO of Cytek Biosciences, Inc.[11]. - The address of the company's principal executive offices is 47215 Lakeview Boulevard, Fremont, California 94538[1].